Crown Holdings, Inc. 10-Q Summary: Q2 2025
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Crown Holdings, Inc. is a global manufacturer of metal packaging products, including beverage cans, food cans, and transit packaging. The company operates through four primary segments: Americas Beverage, European Beverage, Asia Pacific, and Transit Packaging, with additional operations categorized as "Other."
Key Financial Metrics (Six Months Ended June 30, 2025)
| Metric | 2025 (6 Months) | 2024 (6 Months) |
|---|---|---|
| Net Sales | $6,036 million | $5,824 million |
| Income from Operations | $756 million | $624 million |
| Net Income (Attributable to Crown) | $374 million | $241 million |
| Diluted EPS | $3.21 | $2.01 |
| Operating Cash Flow | $463 million | $343 million |
| Capital Expenditures | $89 million | $178 million |
| Total Debt (Principal) | $6,528 million | $6,237 million |
| Cash & Equivalents | $936 million | $918 million |
| Net Leverage Ratio | 2.5x | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3.6% year-over-year, driven by a $214 million pass-through of higher material costs and increased volumes in the Americas and European Beverage segments. This was partially offset by lower volumes in Asia Pacific and Transit Packaging.
- Profitability: Net income attributable to Crown Holdings rose 55% to $374 million. Segment income improved due to better manufacturing performance and volume growth, despite higher restructuring charges.
- Restructuring & Impairments: Restructuring and other charges increased to $45 million (vs. $40 million in 2024), primarily due to asset impairments in China and end-line rationalization in Asia Pacific.
- Debt Refinancing: In May 2025, the company issued $700 million of 5.875% senior notes due 2033 to redeem $875 million of 4.75% notes due 2026, resulting in a $1 million loss on early extinguishment.
- Asbestos Liability: An $11 million reserve was recorded in Q2 2025 following an unfavorable jury verdict in California regarding a mesothelioma wrongful death case.
Guidance, Outlook, and Risks
- Capital Spending: The company expects 2025 capital expenditures to be approximately $450 million.
- Shareholder Returns: The Board authorized a $2,000 million share repurchase program through 2027. The company repurchased $209 million of stock in the first half of 2025. A quarterly dividend of $0.26 per share was declared in July 2025.
- Operational Outlook: Management expects to meet demand growth with current capacity. The company is monitoring the impact of tariffs, trade restrictions, and geopolitical conflicts (Russia-Ukraine, Middle East), though no direct material impact has been observed to date.
- Key Risks:
- Asbestos Litigation: Significant uncertainty remains regarding future claims and the applicability of state legislation limiting liability. The company cannot estimate reasonably possible losses in excess of its $189 million accrual.
- Regulatory & Legal: Ongoing appeals regarding EU antitrust fines ($8 million) and French competition authority fines (€4 million). A U.S. Customs penalty of $18 million is being contested.
- Raw Materials: Fluctuations in aluminum and steel prices, though partially mitigated by pass-through provisions.
Investor Verification Checklist
- Asbestos Accrual Adequacy: Verify the $189 million accrual against the 59,600 outstanding claims and the potential impact of the recent California verdict on future litigation strategy.
- Debt Maturity Profile: Confirm the company's ability to refinance or repay the €500 million ($589 million) senior notes due in February 2026.
- Asia Pacific Performance: Monitor the impact of the Sihanoukville, Cambodia plant closure and the idled Myanmar facility on future segment volumes.
- Regulatory Outcomes: Track the status of appeals for the EU and French antitrust fines and the U.S. Customs penalty.
- Share Repurchase Execution: Assess the pace of the remaining $1,593 million authorized for buybacks relative to cash flow generation.